Acne
Conditions
Interventions
Nadifloxacin
Adapalene
Benzoyl Peroxide
Sponsors
Toshitatsu Nogita
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The patient who is diagnosed as Acne disease (2) Hospitalization or Outpatient: Outpatient (3) Age: over 20 years old (at taking informed consent)
Exclusion criteria
Exclusion criteria: (1) The patient who had a following treatment within 4 weeks prior to the initiation of test drug treatment Facial chemical peering, Leaser therapy, or Phototherapy (2) The patient who had a following treatment within 2 weeks prior to the initiation of test drug treatment Use of Nadifloxacin on his/her face, Facial aesthetic treatment, Use of facial cleanser with scrub (3) The patient who would use or will not stop to use agent for skin (all of prescription medicine and OTC medicine) during the period of the study (4) Pregnant woman, might be pregnant woman, and/or Breastfeeding woman (5) The patient who is hypersensitivity to ingredients of test drug (6) The patient to whom physician recognize him/her will not be included in the study because of his/her history and complication of systemic diseases (7) The patient to who is participating other clinical research or study (8) The patient to whom physician judge as inappropriate for this clinical study due to safely issues
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Level of Nadifloxacin in Follicles of Acne | — |
Countries
Japan
Contacts
Public ContactToshitatsu Nogita
Shinjukuminamiguchihifuka Director
Outcome results
None listed